FDA Approved: ULORIC — Supplemental Application (Takeda Pharmaceuticals America, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for ULORIC (febuxostat) submitted by Takeda Pharmaceuticals America, Inc. The submission status is AP (approved).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gout
• Hyperuricemia

Drugs mentioned

• Uloric (febuxostat)

Snippet

SUPPL AP for ULORIC (FEBUXOSTAT)